Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 676 of 1,261
  1. US 9434695

    Nitrogenous heterocyclic derivatives and their application in drugs

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  2. US 9433666

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  3. US 9433658

    Medical electrode

    Covidien LP · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  4. US 9433601

    Chewing gum compositions comprising cannabinoids

    Stichting Sanammad · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  5. US 9434758

    Non-hormonal steroid modulators of NF-κB for treatment of disease

    ReveraGen BioPharma, Inc. · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  6. US 9433598

    (2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid

    Theravance Biopharma R&D IP, LLC · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  7. US 9433684

    Conjugates of small-interfering nucleic acids

    Nektar Therapeutics · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  8. US 9434717

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  9. US 9433686

    Methods for treating castration resistant prostate cancer and metastasis by reducing B-cell number and/or function

    The Regents of the University of California · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  10. US 9433624

    Methods and compositions for the treatment of metabolic disorders

    BIOMARIN PHARMACEUTICAL INC. · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  11. US 9433632

    Dry coated tablet

    Takeda Pharmaceutical Company Limited · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  12. US 9434931

    Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

    Precision BioSciences, Inc. · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  13. IT UB20150541

    Composizione comprendente sostanze e/o estratti naturali

    ACRAF · Granted Sep 3, 2016 · Expires Aug 29, 2036

    granted
  14. US 9428541

    Substrate reduction therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  15. US 9428749

    Control of whole body energy homeostasis by microRNA regulation

    The Board of Regents of the University of Texas System · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  16. US 9427447

    Anti-viral pyrimidine nucleoside derivatives

    University College Cardiff Consultants Limited · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  17. US 9427410

    Formulation of acoustically activatable particles having low vaporization energy and methods for using same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  18. US 9427422

    Compositions for treating cardiovascular diseases

    Infirst Healthcare Limited · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  19. US 9428467

    Selective calcium channel antagonists

    Northwestern University · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  20. US 9427469

    Soluble physiological chitosan formulations combined with platelet-rich plasma (PRP) for tissue repair

    ORTHO REGENERATIVE TECHNOLOGIES INC. · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  21. US 9428470

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  22. US 9427472

    Controlled release compositions for modulating free-radical induced damage and methods of use thereof

    The Regents of the University of California · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  23. US 9427578

    Pharmacokinetics of iontophoretic sumatriptan administration

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  24. US 9428750

    Oligomeric compounds comprising tricyclic nucleosides and methods for their use

    Ionis Pharmaceuticals, Inc. · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.